KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $3.1 billion.

  • Gilead Sciences' Profit After Tax rose 14357.54% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 billion, marking a year-over-year increase of 633650.79%. This contributed to the annual value of $480.0 million for FY2024, which is 9152.69% down from last year.
  • Per Gilead Sciences' latest filing, its Profit After Tax stood at $3.1 billion for Q3 2025, which was up 14357.54% from $2.0 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Profit After Tax ranged from a high of $3.1 billion in Q3 2025 and a low of -$4.2 billion during Q1 2024
  • For the 5-year period, Gilead Sciences' Profit After Tax averaged around $1.2 billion, with its median value being $1.5 billion (2021).
  • As far as peak fluctuations go, Gilead Sciences' Profit After Tax soared by 521578.95% in 2023, and later tumbled by 51287.13% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Profit After Tax stood at $382.0 million in 2021, then surged by 329.32% to $1.6 billion in 2022, then decreased by 12.87% to $1.4 billion in 2023, then grew by 24.77% to $1.8 billion in 2024, then soared by 71.17% to $3.1 billion in 2025.
  • Its Profit After Tax was $3.1 billion in Q3 2025, compared to $2.0 billion in Q2 2025 and $1.3 billion in Q1 2025.